
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Articles tagged with Mobile from Medical Marketing and Media</title>
        <link>http://www.mmm-online.com/mobile/topic/6590/</link>
        <description>Articles tagged with Mobile from Medical Marketing and Media</description>
        <itunes:author>MMM</itunes:author>
        <itunes:subtitle></itunes:subtitle>
        <itunes:summary></itunes:summary>
        <itunes:owner>
            <itunes:name></itunes:name>
            <itunes:email>mmmsubs@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Business briefs: Medscape, Livestrong, ACA, Lilly</title>
          <description>Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results</description>
          <link>http://www.mmm-online.com/business-briefs-medscape-livestrong-aca-lilly/article/298677/</link>
          <pubDate>Thu, 13 Jun 2013 16:49:30 GMT</pubDate>
          <itunes:summary>Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Lilly, MDLinx launch oncology journal app</title>
          <description>The aggregation tool builds out Lilly&apos;s roster of research apps.</description>
          <link>http://www.mmm-online.com/lilly-mdlinx-launch-oncology-journal-app/article/297315/</link>
          <pubDate>Tue, 11 Jun 2013 16:28:18 GMT</pubDate>
          <itunes:summary>The aggregation tool builds out Lilly&apos;s roster of research apps.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Teva, Celgene, Komen, Apple, OPDP</title>
          <description>Plan B age limits retained and rejected, Celgene drugs gets expanded indication, Komen cuts back on walks, Apple is policing medical apps, OPDP director&apos;s Q&amp;A</description>
          <link>http://www.mmm-online.com/business-briefs-teva-celgene-komen-apple-opdp/article/296684/</link>
          <pubDate>Thu, 06 Jun 2013 17:47:33 GMT</pubDate>
          <itunes:summary>Plan B age limits retained and rejected, Celgene drugs gets expanded indication, Komen cuts back on walks, Apple is policing medical apps, OPDP director&apos;s Q&amp;A</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: AbbVie, Teva, HIV, Diabetes, iPhone</title>
          <description>AbbVie lays off 100 R&amp;D staff; Teva looks to expand Copaxone footprint; researchers crack HIV protein code; monitors may be misleading diabetics and a prototype sensor turns iPhones into virus hunters.</description>
          <link>http://www.mmm-online.com/business-briefs-abbvie-teva-hiv-diabetes-iphone/article/295475/</link>
          <pubDate>Thu, 30 May 2013 15:59:52 GMT</pubDate>
          <itunes:summary>AbbVie lays off 100 R&amp;D staff; Teva looks to expand Copaxone footprint; researchers crack HIV protein code; monitors may be misleading diabetics and a prototype sensor turns iPhones into virus hunters.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>With iPad push, Merck gets global right</title>
          <description>Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.</description>
          <link>http://www.mmm-online.com/with-ipad-push-merck-gets-global-right/article/295046/</link>
          <pubDate>Mon, 27 May 2013 19:54:45 GMT</pubDate>
          <itunes:summary>Merck came late to the iPad party, but the company has made up the distance by releasing a global template for details using the device.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Mayo device helps monitor heart patients from afar</title>
          <description>Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world.</description>
          <link>http://www.mmm-online.com/mayo-device-helps-monitor-heart-patients-from-afar/article/294386/</link>
          <pubDate>Wed, 22 May 2013 14:59:55 GMT</pubDate>
          <itunes:summary>Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Pfizer, BMS, CMS, Sanofi</title>
          <description>Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi&apos;s iBGStar may have a competitor.</description>
          <link>http://www.mmm-online.com/business-briefs-pfizer-bms-cms-sanofi/article/293671/</link>
          <pubDate>Thu, 16 May 2013 16:50:50 GMT</pubDate>
          <itunes:summary>Pfizer cuts 136 workers loose in Ireland, BMS is investing in heart failure treatments, CMS has an official new leader, and Sanofi&apos;s iBGStar may have a competitor.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business briefs: Bayer, FDA, Ranbaxy</title>
          <description>Bayer&apos;s prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations</description>
          <link>http://www.mmm-online.com/business-briefs-bayer-fda-ranbaxy/article/293533/</link>
          <pubDate>Wed, 15 May 2013 19:13:18 GMT</pubDate>
          <itunes:summary>Bayer&apos;s prostate cancer drug clears FDA three months early; a House committee is pressing the regulator for employment transparancy; and Ranbaxy takes a multi-million dollar hit over violations</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>Business Briefs Merck, GSK, Novo, Walgreen, Epocrates, Doximity</title>
          <description>HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets.</description>
          <link>http://www.mmm-online.com/business-briefs-merck-gsk-novo-walgreen-epocrates-doximity/article/292622/</link>
          <pubDate>Thu, 09 May 2013 14:56:06 GMT</pubDate>
          <itunes:summary>HPV vaccine price cut; Merck files new allergy med with FDA; GSK pursues online transparency; Walgreens ready for greater nurse autonomy; Epocrates ranks high among docs with tablets.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
        <item>
          <title>WebMD on the hunt for new business</title>
          <description>The CEO&apos;s unexpected departure is part of the health information brand&apos;s latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.</description>
          <link>http://www.mmm-online.com/webmd-on-the-hunt-for-new-business/article/292516/</link>
          <pubDate>Wed, 08 May 2013 16:41:36 GMT</pubDate>
          <itunes:summary>The CEO&apos;s unexpected departure is part of the health information brand&apos;s latest changes. On the table: possible acquisitions. In progress: a new federal contract and new website content. Ignored: if the company wants to be bought.</itunes:summary>
          <itunes:author>MMM</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  